About Biophytis SA American Depositary Share
Biophytis SA, a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases and the treatment of severe respiratory failure in patients suffering from COVID-19. Its therapeutics focuses on targeting and activating key biological resilience pathways that could protect against and counteract the effects of the multiple biological and environmental stresses that lead to age-related diseases. The company’s lead drug candidate, Sarconeos (BIO101), is an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and Duchenne muscular dystrophy (DMD). Its second drug candidate, Macuneos (BIO201), is an orally administered small molecule in development for the treatment of retinal diseases, including dry ager elated macular degeneration (AMD) and Stargardt disease. Biophytis SA has a collaboration agreement with AFM-Telethon for the development of its Sarconeos (BIO101) for the treatment of DMD. The company was incorporated in 2006 and is based in Paris, France. Address: Sorbonne University, Paris, France, 75005
Biophytis SA American Depositary Share News and around…
Latest news about Biophytis SA American Depositary Share (BPTS) common stock and company :
InvestorPlace - Stock Market News, Stock Advice & Trading Tips It's time for another dive into the biggest pre-market stock movers as we check out the latest news for Wednesday morning! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips We're starting off Tuesday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on today! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.
Gainers BIMI Intl Medical (NASDAQ:BIMI) stock moved upwards by 90.8% to $1.17 during Monday's after-market session. ...
Gainers Hanger (NYSE:HNGR) stock moved upwards by 27.1% to $18.75 during Thursday's after-market session. The company's market cap ...
Gainers NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares increased by 15.1% to $0.63 during Wednesday's after-market session. The ...
Gainers Direct Digital Holdings, Inc. (NASDAQ: DRCT) shares surged 82.2% to $2.6787. Direct Digital Holdings said its supply-side ...
Gainers ThermoGenesis Holdings (NASDAQ:THMO) shares increased by 65.2% to $0.38 during Wednesday's regular session. ...
Gainers Nuwellis (NASDAQ:NUWE) stock increased by 52.4% to $0.92 during Tuesday's regular session. Nuwellis's ...
Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) rose 56.1% to $ 0.7029 after dropping 10% on Thursday. Allena ...
Gainers Quoin Pharmaceuticals (NASDAQ:QNRX) stock increased by 84.7% to $0.83 during Friday's pre-market session. ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! It's time for another look at the biggest pre-market stock movers as we dive into the latest news for Friday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday appeared first on InvestorPlace. More From InvestorPlace $200 Oil Sooner Than You Think – Buy This Now The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 in savings or $5 million. Do this now.
Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) rose 83.2% to $0.8250 in pre-market trading after dropping 10% on ...
Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. ...
On June 14, 2021, Biophytis announced a convertible line of €32 million from Atlas. The financing instrument allows the issuance of 1,280 ORNANE, at a par value of €25,000 each.
Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 171.3% to $1.70 after jumping 27% on Wednesday. Revelation ...
PARIS, FRANCE and CAMBRIDGE, MASSACHUSETTS / ACCESSWIRE / June 27, 2022 / Biophytis SA (NASDAQ:BPTS)(Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes in patients suffering from age-related diseases, announced today that it is giving an oral presentation on the development of Sarconeos (BIO101) for the treatment of sarcopenia at the 15th International SCWD Congress (Society on Sarcopenia, Cachexia & Wasting disorders).
Thanks to the mobilization of shareholders, the CGM could be held on second call with a quorum of more than 23% of the shareholders present or represented. The results of the votes of the combined General Meeting will be available on Biophytis' website from June 23, 2022, under the section - Investors - General Assembly.
Gainers Day One Biopharmaceutical (NASDAQ:DAWN) stock increased by 106.0% to $13.64 during Monday's regular session. ...
PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / June 3, 2022 / Biophytis SA (NASDAQ:BPTS)(Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging, including severe respiratory failure in patients suffering from COVID-19, informs its shareholders that the combined Annual General Meeting (AGM) held on June 3, 2022 was unable to deliberate, as the required quorum was not reached.
Gainers GeoVax Labs, Inc. (NASDAQ: GOVX) shares surged 90.2% to settle at $1.39 on Friday. GeoVax Labs, last month, said its Q1 ...
On Tuesday, 123 stocks made new 52-week lows. Noteworthy Points From Today's 52-Week Lows: The largest company by ...
Biophytis' participation in BIO is aligned with the Company's strategy to partner with global or regional players to license and co-develop its core assets. More particularly, the Company is actively seeking partners to continue the development of Sarconeos (BIO101) in Phase 2/3 in Sarcopenia and to distribute the product in COVID-19-related respiratory failure if Phase 2/3 is successful and emergency use authorisation is granted.
Gainers ION Geophysical Corporation (NYSE: IO) shares surged 91.2% to settle at $0.6980 on Wednesday. ION Geophysical was awarded ...
PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / April 19, 2022 / Biophytis SA ((NASDAQ:BPTS)(Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging, including severe respiratory failure in patients suffering from COVID-19, today announces it will present and discuss the results of Sarconeos (BIO101) development program in Sarcopenia at the 12th annual International Conference on Frailty and Sarcopenia Research (ICFSR) to be held virtually and on site in Boston from April 20 to April 22, 2022.
Gainers Alzamend Neuro (NASDAQ:ALZN) shares rose 19.6% to $1.22 during Tuesday's after-market session. Today's trading volume for ...
Gainers Trevi Therapeutics (NASDAQ:TRVI) stock rose 45.8% to $2.77 during Thursday's regular session. Trevi ...
Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) jumped 57.6% to $1.3515. Ally Bridge Group reported a purchase of 21.176 million ...
Gainers IMAC Holdings (NASDAQ:IMAC) shares increased by 60.0% to $1.6 during Thursday's pre-market session. The market value of their ...
Biophytis SA(NASDAQ: BPTS) said that it iscurrently assessing FDA comments and recommendationsand preparing to ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips We're diving into the biggest pre-market stock movers for Thursday that investors are going to want to keep track of today. The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS It doesn’t matter if you have $500 in savings or $5 million. Do this now. 10 Stocks Are Issuing Sell Signals Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”
Biophytis SA American Depositary Share (BPTS) is a NASDAQ Common Stock listed in Biotechnology, Common Stock, Healthcare
